Differentiation defects in primary motoneurons from a SMARD1 mouse model that are insensitive to treatment with low dose PEGylated IGF1
Rare Diseases · 2014-01 · 2 (1) · e29415
DOI: 10.4161/rdis.29415 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rare Diseases, online erschienen am 10.06.2014. Verfasst von Frank Krieger und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Clinical Neurobiology; University of Wuerzburg; Wuerzburg, Germany. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Clinical Neurobiology; University of Wuerzburg; Wuerzburg, Germany.
- Roche Pharmaceutical Research and Early Development; Roche Innovation Center Basel; F. Hoffmann-La Roche Ltd.; Basel, Switzerland.
Zitieren
APA
Krieger, F., Metzger, F., & Jablonka, S. (2014). Differentiation defects in primary motoneurons from a SMARD1 mouse model that are insensitive to treatment with low dose PEGylated IGF1. Rare Diseases, 2(1), e29415. https://doi.org/10.4161/rdis.29415
Vancouver
Krieger F, Metzger F, Jablonka S. Differentiation defects in primary motoneurons from a SMARD1 mouse model that are insensitive to treatment with low dose PEGylated IGF1. Rare Diseases. 2014;2(1):e29415. doi:10.4161/rdis.29415
BibTeX
@article{Krieger2014,
author = {Krieger, Frank and Metzger, Friedrich and Jablonka, Sibylle},
title = {Differentiation defects in primary motoneurons from a SMARD1 mouse model that are insensitive to treatment with low dose PEGylated IGF1},
journal = {Rare Diseases},
year = {2014},
volume = {2},
number = {1},
pages = {e29415},
doi = {10.4161/rdis.29415}
}
EUVIMED